Viewing StudyNCT00099502



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00099502
Status: COMPLETED
Last Update Posted: 2008-12-19
First Post: 2004-12-15

Brief Title: BEYOND BetaferonBetaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis MS Patients
Sponsor: Bayer
Organization: Bayer

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis Relapsing-Remitting
Keywords:
Name View
Betaseron View
Relapsing multiple sclerosis View
interferon beta 1b View
Betaferon View